Clinical Trials Browser

Interventional × AZD 6244 × Myeloid × Clear all

NCT03326310 2025-12-29

Selumetinib and Azacitidine in High Risk Chronic Blood Cancers

Phase 1 Recruiting

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Primary Myelofibrosis

NCT00588809 2015-08-05

Selumetinib in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia

Phase 2 Completed

47 enrolled 9 charts

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute, Myelodysplastic-Myeloproliferative Diseases